2014
DOI: 10.1016/j.gie.2013.11.003
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation and management of small-bowel tumors in the era of deep enteroscopy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
41
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(41 citation statements)
references
References 96 publications
0
41
0
Order By: Relevance
“…The most common malignancy lesions are adenocarcinoma, neuroendocrine tumor (NET), sarcomas, and small bowel lymphoma. However, the incidence of small bowel cancer is increasing, particularly for carcinoid tumor (Islam, 2014). The small bowel is not a common location of metastatic cancers, although there are many case reports Based on radiology and endoscopy, this study revealed upper gastrointestinal bleeding, an intra-abdominal mass, and a sub-epithelial mass as common symptoms of GIST.…”
mentioning
confidence: 70%
See 1 more Smart Citation
“…The most common malignancy lesions are adenocarcinoma, neuroendocrine tumor (NET), sarcomas, and small bowel lymphoma. However, the incidence of small bowel cancer is increasing, particularly for carcinoid tumor (Islam, 2014). The small bowel is not a common location of metastatic cancers, although there are many case reports Based on radiology and endoscopy, this study revealed upper gastrointestinal bleeding, an intra-abdominal mass, and a sub-epithelial mass as common symptoms of GIST.…”
mentioning
confidence: 70%
“…Upper gastrointestinal study with small bowel followthrough, ultrasonography of the whole abdomen, computed tomography (CT) scan, CT and enteroclysis/ enterography, video capsule enteroscopy (VCE), esophagogastroduodenoscopy (EGD), and balloonassisted enteroscopy (BAE) were commonly used to determine localization of the tumor and to evaluate adjacent organs (Islam et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…27 The prevalence of small bowel tumors in patients with OGIB has been reported to range between 5% and 10%, 28,29 malignant tumors accounting for 60% to 75% of cases. 27 In a large multicenter study, 29 the main primary small bowel tumor type was gastrointestinal stromal tumor (GIST) (32%), followed by adenocarcinoma (20%) and carcinoid tumor (15%) (Fig. 2); two thirds of metastatic tumors in the small bowel corresponded to melanomas.…”
Section: Small Bowel Tumors and Polyposis Syndromesmentioning
confidence: 99%
“…Nonetheless, in clinical practice, the tumor is often diagnosed by SBCE in the first place, in patients being investigated for OGIB; subsequently, patients will often undergo crosssectional imaging for staging and eventually proceed to BAE to obtain biopsies for histopathologic diagnosis; BAE may also be used to remove retained capsules proximal to the tumor, as the risk of capsule retention has been reported to be high in this population, ranging from 1.4% to 17%. 27 From a practical point of view, if there is a suspicion of small bowel tumor based on previous cross-sectional imaging studies, BAE could be preferred over SBCE, in order to avoid the risk of capsule retention and to allow biopsies for histopathologic diagnosis. The diagnostic yield of DBE has been shown to be similar to the combination of CTE and SBCE, 33 and the specificity is higher, mainly due to the high rate of false positive submucosal masses detected by SBCE.…”
Section: Small Bowel Tumors and Polyposis Syndromesmentioning
confidence: 99%
“…3 The diagnosis of small bowel tumor is really challenging even in the modern medicine when novel approaches such as video capsule endoscopy and nuclear magnetic resonance (NMR) are available. [5][6][7][8][9][10][11][12] Here, we report the diagnosis of small bowel cancer with NMR in a patient presenting with intestine sub-occlusion.…”
Section: Introductionmentioning
confidence: 99%